دورية أكاديمية

Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial

التفاصيل البيبلوغرافية
العنوان: Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial
المؤلفون: Ringshausen, Felix C, Shapiro, Adam J, Nielsen, Kim G, Mazurek, Henryk, Pifferi, Massimo, Donn, Karl H, van der Eerden, Menno M, Loebinger, Michael R, Zariwala, Maimoona A, Leigh, Margaret W, Knowles, Michael R, Ferkol, Jr, Thomas W, Brown, Trey, Carroll, Mary, Church, Nina, Couluris, Marisa, Davis, Stephanie D, Dell, Sharon D, Di Cicco, Maria E, Di Mango, Angela, Escobar, Hugo, Griffiths, Anne, Haver, Kenan, Hornick, Douglas, Johnson, Christopher, Milla, Carlos E, O'Donnell, Anne, Pink, Isabell, Pogorzelski, Andrzej, Prickett, Michelle, Raby, Benjamin A, Rosenfeld, Margaret, Saba, Thomas G, Sandvik, Rikke Mulvad, Sagel, Scott D, Salathe, Matthias, Simmons, Ashley E, Solomon, George M, Sommerburg, Olaf, Soussi, Najwa, Strausbaugh, Steven D, Sullivan, Kelli M, Werner, Claudius, Ferkol, Thomas W
المصدر: In The Lancet Respiratory Medicine January 2024 12(1):21-33
قاعدة البيانات: ScienceDirect
الوصف
تدمد:22132600
DOI:10.1016/S2213-2600(23)00226-6